IL55115A - 3-indolyl-tert-butylamino-propanol derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

3-indolyl-tert-butylamino-propanol derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL55115A
IL55115A IL55115A IL5511578A IL55115A IL 55115 A IL55115 A IL 55115A IL 55115 A IL55115 A IL 55115A IL 5511578 A IL5511578 A IL 5511578A IL 55115 A IL55115 A IL 55115A
Authority
IL
Israel
Prior art keywords
compound
alkyl
formula
compounds
indolyl
Prior art date
Application number
IL55115A
Other languages
English (en)
Other versions
IL55115A0 (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IL55115A0 publication Critical patent/IL55115A0/xx
Publication of IL55115A publication Critical patent/IL55115A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL55115A 1977-07-13 1978-07-10 3-indolyl-tert-butylamino-propanol derivatives,their preparation and pharmaceutical compositions containing them IL55115A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81513877A 1977-07-13 1977-07-13

Publications (2)

Publication Number Publication Date
IL55115A0 IL55115A0 (en) 1978-09-29
IL55115A true IL55115A (en) 1981-09-13

Family

ID=25216976

Family Applications (1)

Application Number Title Priority Date Filing Date
IL55115A IL55115A (en) 1977-07-13 1978-07-10 3-indolyl-tert-butylamino-propanol derivatives,their preparation and pharmaceutical compositions containing them

Country Status (30)

Country Link
JP (1) JPS5419972A (fi)
AR (1) AR225274A1 (fi)
AT (1) AT364821B (fi)
AU (1) AU525064B2 (fi)
BE (1) BE868943A (fi)
CA (1) CA1116598A (fi)
CH (1) CH642066A5 (fi)
CY (1) CY1274A (fi)
DE (1) DE2830884A1 (fi)
DK (1) DK156568C (fi)
ES (1) ES471674A1 (fi)
FI (1) FI69835C (fi)
FR (1) FR2397404A1 (fi)
GB (1) GB2001633B (fi)
GR (1) GR74488B (fi)
HK (1) HK1385A (fi)
HU (1) HU178992B (fi)
IE (1) IE47122B1 (fi)
IL (1) IL55115A (fi)
IT (1) IT1105091B (fi)
KE (1) KE3485A (fi)
LU (1) LU79966A1 (fi)
MY (1) MY8500946A (fi)
NL (1) NL189946C (fi)
NO (1) NO149311C (fi)
NZ (1) NZ187763A (fi)
SE (1) SE429339B (fi)
SG (1) SG82584G (fi)
YU (1) YU40528B (fi)
ZA (1) ZA783744B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2463765A1 (fr) * 1979-08-17 1981-02-27 Clin Midy Nouveaux derives de l'indole actifs sur le systeme cardiovasculaire
US4321398A (en) * 1981-05-07 1982-03-23 Mead Johnson & Company Thienyl and benzothienyl-tertiary butylaminophenoxypropanols
DE3119796A1 (de) * 1981-05-19 1982-12-23 Hoechst Ag, 6000 Frankfurt Substituierte tryptaminderivate von thienyloxpropanolaminen, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen sowie ihre verwendung
FR2523964B1 (fr) * 1982-03-23 1985-09-27 Sanofi Sa Nouveaux derives de la tryptamine actifs notamment sur le systeme cardiovasculaire et procede pour leur preparation
NZ208337A (en) * 1983-06-10 1988-10-28 Bristol Myers Co 2-(2-hydroxy-3-((2-(ar-hydroxy-1h-aminopropoxy-yl)ethyl benzonitriles and pharmaceutical compositions
FR2601008B1 (fr) * 1986-07-03 1990-03-30 Sanofi Sa Procede de synthese stereospecifique de derives de l'indole
EP1341759B1 (en) 2000-11-10 2006-06-14 Eli Lilly And Company 3-substituted oxindole beta 3 agonists
EP1444224B1 (en) 2001-08-14 2006-05-03 Eli Lilly And Company 3-substituted oxindole beta-3 agonists
ATE340794T1 (de) 2001-08-14 2006-10-15 Lilly Co Eli Indol derivate als beta-3-adrenerge agonisten zur behandlung von typ 2 diabetes
US7205407B2 (en) 2001-11-20 2007-04-17 Eli Lilly And Company 3-Substituted oxindole β3 agonists
AU2002353844A1 (en) 2001-11-20 2003-06-10 Eli Lilly And Company Beta 3 adrenergic agonists
EP1467733A1 (en) 2002-01-11 2004-10-20 Eli Lilly And Company 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
CA2960254A1 (en) 2008-08-01 2010-02-04 Arca Biopharma, Inc. Methods and compositions involving (s)-bucindolol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1532210A (fr) * 1963-06-21 1968-07-12 Ici Ltd Composés hétérocycliques et leur procédé de préparation
CH495983A (de) * 1968-02-09 1970-09-15 Sandoz Ag Verfahren zur Herstellung von linksdrehendem 4-(2-Hydroxy-3-isopropylaminopropoxy)indol
US3371098A (en) * 1966-11-29 1968-02-27 Philips Corp 5- and 6-methoxy-3-(phenoxyethyl-aminoethyl)-indoles
US3946009A (en) * 1972-05-05 1976-03-23 Merck Sharp & Dohme (I.A.) Corporation 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazines

Also Published As

Publication number Publication date
NL189946C (nl) 1993-09-16
IE47122B1 (en) 1983-12-28
FR2397404A1 (fr) 1979-02-09
FI69835C (fi) 1986-05-26
IE781400L (en) 1979-01-13
DK156568C (da) 1990-02-05
FI782205A (fi) 1979-01-14
CH642066A5 (de) 1984-03-30
AR225274A1 (es) 1982-03-15
NZ187763A (en) 1984-07-31
ES471674A1 (es) 1979-10-01
YU40528B (en) 1986-02-28
AU525064B2 (en) 1982-10-21
NO149311C (no) 1984-03-28
NO782407L (no) 1979-01-16
SE7807700L (sv) 1979-01-14
DE2830884C2 (fi) 1990-01-11
KE3485A (en) 1985-01-25
AU3770478A (en) 1980-01-10
IL55115A0 (en) 1978-09-29
DK313878A (da) 1979-01-14
ATA508978A (de) 1981-04-15
DK156568B (da) 1989-09-11
FI69835B (fi) 1985-12-31
ZA783744B (en) 1979-07-25
IT1105091B (it) 1985-10-28
CA1116598A (en) 1982-01-19
NL7807564A (nl) 1979-01-16
LU79966A1 (fr) 1979-04-09
FR2397404B1 (fi) 1982-06-11
IT7850228A0 (it) 1978-07-10
MY8500946A (en) 1985-12-31
GR74488B (fi) 1984-06-28
HU178992B (en) 1982-07-28
GB2001633A (en) 1979-02-07
NL189946B (nl) 1993-04-16
SG82584G (en) 1985-09-13
YU161178A (en) 1983-02-28
JPS6340784B2 (fi) 1988-08-12
DE2830884A1 (de) 1979-02-01
HK1385A (en) 1985-01-11
AT364821B (de) 1981-11-25
SE429339B (sv) 1983-08-29
CY1274A (en) 1985-03-08
JPS5419972A (en) 1979-02-15
BE868943A (fr) 1979-01-12
GB2001633B (en) 1982-03-24
NO149311B (no) 1983-12-19

Similar Documents

Publication Publication Date Title
US4234595A (en) 3-Indolyl-tertiary butylaminopropanols
US4012444A (en) 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
SU1349700A3 (ru) Способ получени (2-оксо-1,2,3,5-тетрагидроимидазо-/2,1- @ /хиназолинил)оксиалкиламидов,их оптических изомеров или фармакологически приемлемых солей с кислотами
US4072759A (en) Novel benzylalcohol derivatives as antidiabetics and cardiotonics
IL55115A (en) 3-indolyl-tert-butylamino-propanol derivatives,their preparation and pharmaceutical compositions containing them
JPS6354321A (ja) 血糖降下剤
IE44904B1 (en) Aminophosphonous acids and processes for their preparation
JPS6028979A (ja) イミダゾキナゾリン類化合物
US4314943A (en) Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
GB2190677A (en) 1-(hydroxystyryl)-5h-2,3-benzodiazepine derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
US4056626A (en) Pharmaceutical composition containing benzofuran derivative
EP0089634B1 (en) Phenoxypropanolamine derivatives
IE44339B1 (en) Piperazine derivatives
FR2521140A1 (fr) Derives d'imidazolidine, leur preparation et leur application en therapeutique
EP0161498B1 (en) Phenylpiperazine derivatives and their acid addition salts
IE43797B1 (en) Esters of indole-derived amino alcohols
US3920691A (en) 5-(3-substituted amino-2-hydroxypropoxy)-1,3-disubstituted pyrazoles and method of preparation
US3975524A (en) 3-Piperazino-isoquinolines and salts thereof
GB2120251A (en) Dihydropyridines
HU214337B (hu) Eljárás 1,3,4-tiadiazin-2-on-származékok és az azokat tartalmazó gyógyszer készítmények előállítására
EP0150235A1 (en) Derivatives of 3-pyrrolidinopropiophenone and a process for preparation thereof
US4066755A (en) Phenylaminoethanol derivatives for treating hypertension
US3959476A (en) Antihypertensive substituted triazoles
HU178147B (en) Process for producing hexahydro-1,4-oxazepines
JPS61122275A (ja) 新規ヒダントイン誘導体及び該化合物を含有する医薬組成物

Legal Events

Date Code Title Description
KB Patent renewed